Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05017532
Other study ID # RC2S
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 6, 2022
Est. completion date December 2024

Study information

Verified date October 2023
Source Douglas Mental Health University Institute
Contact Karyne Anselmo, M.Sc.
Phone 514-761-6131
Email karyne.anselmo@douglas.mcgill.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will investigate whether the remote administration of the cognitive remediation program RC2S+ acceptable and feasible in people with schizophrenia and related disorders.


Description:

Schizophrenia and related psychotic disorders are associated with major functioning difficulties encompassing various areas of everyday life such as social interactions or school and work performance. Cognition, and more particularly social cognition, defined as the mental processes underlying social interactions, is considered as one of the best predictors of functioning in schizophrenia and related psychotic disorders. Social cognitive deficits thus represent a promising treatment target to promote functional recovery. Cognitive remediation (CR) is a behavioural intervention that can improve social cognitive deficits and clinical symptoms and moderate to large effect sizes have been reported. While there is great excitement that such interventions can also improve functioning, very few CR program for social cognition have used a personalized approach to tailor treatment to individual difficulties despite the benefit of personalizing CR treatment in schizophrenia. The program Remédiation Cognitive de la Cognition Sociale en Schizophrénie (RC2S+) is a personalized CR treatment targeting social cognition using virtual reality to emulate daily social interactions. Two case studies conducted in France with people with schizophrenia have demonstrated acceptability and feasibility of in-person RC2S+ while providing preliminary evidence for efficacy with the report of significant improvement of social cognitive and functional difficulties. While these preliminary results are encouraging, the program has never been used in Canada. Psychosocial intervention, and particularly those targeting social cognition, need to be culturally adapted. Thus, a preliminary study is necessary to assess if RC2S+ is culturally adapted to the social norms and rules of French and English-speaking Canadians. Further, this study needs to consider the actual context of the COVID-19 pandemic which has highlighted the important vulnerability of people with psychotic disorders and the need to adapt evidence-based interventions such as CR to increase access to mental healthcare services. Online interventions have rapidly developed in the last year in response to COVID-19 and these interventions address important factors that are known to limit access to psychiatric care in people with psychotic disorders. A remote version will however require an acceptability and feasibility assessment. Our main objective is to assess the acceptability, feasibility, and preliminary effect of the remoted RC2S+. To reach this goal, we will, 1) Translate the RC2S+ program in English and adapt the program for French Canadians and 2) Determine the acceptability, the feasibility and the preliminary effect of the remoted RC2S+. Twenty-six participants with a diagnosis of schizophrenia and related psychotic disorder aged 18 years or older and who present with at least one social cognitive impairment will be recruited. They will be initially assessed for social cognition as well as clinical outcomes (e.g. symptoms, recovery, functioning). Then, participants will receive 24 biweekly individual sessions of RC2S+ of 1 hour with a therapist. Intra-session questionnaires will be administered at different timepoints to the participants and the therapists to assess therapeutic alliance, motivation toward treatment as well as the satisfaction regarding treatment. At the end of treatment, participants will be reassessed with the similar measures as baseline. This study will provide the first insight of the preliminary effect of RC2S+ administered remotely, in addition to providing French-Canadian and English version of this novel program. The results of the current study will provide relevant information to improve the program and its delivery for a future efficacy study.


Recruitment information / eligibility

Status Recruiting
Enrollment 26
Est. completion date December 2024
Est. primary completion date August 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. DSM-5 diagnosis of schizophrenia or a related psychotic disorder 2. Being followed and treated by a clinician of the Douglas Mental Health University Hospital 3. Being 18 or older 4. Having an objective difficulty in social cognition (i.e. emotion recognition, theory of mind, attributional bias, social perception) defined as a performance equal of below 1 standard deviation from the normative group on one of the following measures: Penn Emotion Recognition Task (ER-40; Emotion recognition), Combined Stories Test (COST; Theory of mind), Social Knowledge test (SKT; Social knowledge) or Interpersonal, Personal and Situational Attributions Questionnaire (IPSAQ; Attributional style). This criterion is mandatory since we need to be able to remediate a difficulty during cognitive remediation. 5. Being considered symptomatically stable and capable of using the online platforms, as judged by their primary clinicians (i.e., psychiatrist, case manager, psychologist) 6. Having access to digital technology, Internet and access to a private space (a room where the participant can be alone) 7. Being able to nominate an emergency contact Exclusion Criteria: 1. Evidence of an organic cause for cognitive difficulties (e.g. neurological disease, history of brain trauma) 2. History of mental retardation or autism spectrum disorder 3. Being hospitalized at the time of recruitment 4. Inability to speak or read French or English

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
The program Remédiation Cognitive de la Cognition Sociale en Schizophrénie (RC2S+)
The program Remédiation Cognitive de la Cognition Sociale en Schizophrénie (RC2S+) is a personalized CR treatment targeting social cognition (e.g. theory of mind, emotion recognition) using virtual reality to emulate daily social interactions

Locations

Country Name City State
Canada Douglas Mental Health University Institute Montréal Quebec

Sponsors (1)

Lead Sponsor Collaborator
Douglas Mental Health University Institute

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Other NIMH suicide screening questionnaire (NIMH-SSQ) This questionnaire includes five questions to screen for suicide risk. The administration time is estimated at 5 minutes.
Other Échelle de repercussions fonctionnelles des troubles de la cognition sociale (ERF-CS) This short semi-structured interview explores the presence and impact of various social cognitive deficits in everyday life. The interview also assesses how much the participant is bothered by these difficulties. The administration time is estimated at 10 minutes.
Other Goal Attainment Scale (GAS) The GAS is a flexible scale that allows the elaboration of personalized objectives before starting treatment that will be reassessed at follow-ups. The scale is rated on a scale from -2 to +2. A score of 0 indicates that the participant has reached his initial goal. Scores of +1 or +2 are obtained if the participant has exceeded or greatly exceeded his initial goal. Scores of -1 and -2 are obtained if the participant did not completely or not all reached his objective. When the objectives are set, an operational definition is established for each level of ratings. The administration time is estimated at 5 minutes.
Other MUSIC® Model of Motivation Inventory, Cognitive Training version (MMI-CT) The MMI-CT is an 18-item self-report questionnaire that assesses motivation toward cognitive training. The questionnaire is divided into five scales namely empowerment, usefulness, success, interest and caring. Responses range from 1 (Strongly disagree) to 6 (Strongly Agree). The administration time is estimated at 5 minutes.
Other Working Alliance Inventory Short form (WAI) The WAI I is a self-report questionnaire of 36 items rated on a Likert scale from 1 (Never) to 7 (Always) to assess therapeutic alliance. The administration time is estimated at 5 minutes.
Other eTherapy Attitudes and Process questionnaire (eTAP) The eTAP is a self-report questionnaire that measures factors related to client engagement in e-interventions for mental health. There are 16 questions rated on a Likert scale ranging from 1 to 7. The administration time is estimated at 5 minutes.
Other RC2S+ Acceptability, Usability, Safety, Impact, and Satisfaction Questionnaire (RC2S+-AUSIS-Q) This questionnaire was built for this project, based on a similar questionnaire created by our team in a previous project (iCog-AUSI-Q). The administration time is estimated at 5 minutes.
Primary Combined Stories Test (COST) This test assesses Theory of Mind (ToM) abilities and includes 30 short verbal stories. Participants are asked to read each story out loud and are asked to answer ToM and control questions. The administration time is estimated at 30 minutes.
Primary Social Knowledge Test (SKT) This test assesses social knowledge. Participants are presented with a series of short hypothetical situations and are asked to state how they think most people in this situation would feel. The administration time is estimated at 5 minutes.
Primary Penn Emotion Recognition Task (ER-40) This test assesses emotion recognition on faces. A total of 40 faces are presented to the participants who must choose between five different emotions. The administration time is estimated at 10 minutes.
Primary Interpersonal, Personal and Situational Attributions Questionnaire (IPSAQ) This test assesses attributional style. Participants are presented with 32 social situations and for each of them, they must decide what was the main cause of the event described in each statement and select if the cause is whether because of them, because of another person or because of the situation. The administration time is estimated at 10 minutes.
Secondary DACOBS: Davos Assessment of Cognitive Biases Scale This questionnaire assesses cognitive biases through 42 items rated on a Likert scale from 1 (strongly disagree) to 7 (strongly agree). The administration time is estimated at 10 minutes.
Secondary PANSS-6: Positive and Negative Syndrome Scale Through a semi-structured interview, the positive and negative symptomatology of schizophrenia is explored. In this reduced scale, the following symptoms are assessed: delusions, conceptual disorganization, hallucinations, flattened affect, passive social withdrawal, and poverty of speech. The administration time is estimated at 20 minutes.
Secondary Social Interaction Anxiety Scale (SIAS) The SIAS is a 20 items self-report questionnaire to assess social anxiety. This questionnaire provides a clinical picture of the cognitive, affective, and behavioral reactions to interactional situations. The administration time is estimated at 5 minutes.
Secondary Patient Health Questionnaire (PHQ-9) this questionnaire assesses the principal diagnostic criteria of major depression. The administration time is estimated at 5 minutes.
Secondary First-episode social functioning scale (FESF) This self-report questionnaire aims to assess functioning in several areas including productive activities (e.g. school, work), social functioning (e.g. family, friends, acquaintances) and instrumental activities of daily living (e.g. transportation, money management). Items are rated on a Likert scale ranging from "completely disagree" to "completely agree" for the ability of the participant to perform the activity, and on a scale ranging from "Never" to "Always" for the frequency of the activity (with the option never if the activity is not performed by the participant). The administration time is estimated at 10 minutes.
Secondary The Questionnaire about the process of recovery (QPR) The QPR is a 22 item self- report measure measuring the process of recovery from a psychotic disorder. The items are rated on a five-point Likert scale ranging from "strongly disagree" to "strongly agree". The administration time is estimated at 5 minutes.
See also
  Status Clinical Trial Phase
Recruiting NCT05039489 - A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia N/A
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT05321602 - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder Phase 1
Completed NCT04503954 - Efficacy of Chronic Disease Self-management Program in People With Schizophrenia N/A
Completed NCT02831231 - Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium Phase 1
Completed NCT05517460 - The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center N/A
Completed NCT03652974 - Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy Phase 4
Recruiting NCT04012684 - rTMS on Mismatch Negativity of Schizophrenia N/A
Recruiting NCT04481217 - Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia N/A
Completed NCT00212784 - Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) Phase 3
Completed NCT04092686 - A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia Phase 3
Completed NCT01914393 - Pediatric Open-Label Extension Study Phase 3
Recruiting NCT03790345 - Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics Phase 2/Phase 3
Recruiting NCT05956327 - Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training N/A
Terminated NCT03261817 - A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders N/A
Terminated NCT03209778 - Involuntary Memories Investigation in Schizophrenia N/A
Completed NCT02905604 - Magnetic Stimulation of the Brain in Schizophrenia or Depression N/A
Recruiting NCT05542212 - Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia N/A
Completed NCT04411979 - Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia N/A
Terminated NCT03220438 - TMS Enhancement of Visual Plasticity in Schizophrenia N/A